Zymeworks scores $61.5 mln Series A

By Iris Dorbian — 4 weeks ago

Vancouver, British Columbia-based Zymeworks, a biotherapeutics company, has raised $61.5 million in Series A funding. BDC Capital and Lumira Capital led the round with participation from other investors that included Eli Lilly and Company, Celgene, CTI Life Sciences Fund, the Fonds de solidarité FTQ. Perceptive Advisors, Teralys Capital, Northleaf Venture Catalyst Fund, Brace Pharma Capital and Merlin Nexus. In addition to the funding, Dion Madsen, a senior managing partner at BDC Capital’s healthcare venture fund, has been added to Zymeworks’ board of directors while Dr. Daniel Hétu, a managing director at Lumira Capital, will become an observer.

Continue

First Aid Shot Therapy rakes in $24 mln Series C

By Iris Dorbian — 3 months ago

Burlingame, California-based First Aid Shot Therapy, a developer of over-the-counter medicine in liquid shot form, has raised $24 million in Series C funding. Johnson & Johnson Innovation – JJDC Inc led the round with participation from other investors that included Lumira Capital, Sofinnova Ventures, Redmile Group and HealthQuest Capital.

Continue

Cardiac Dimensions nabs $15.2 mln

By Iris Dorbian — 11 months ago

Cardiac Dimensions, a developer of minimally invasive treatments that address heart failure and related cardiovascular conditions, has raised $15.2 million in funding. The investors included Life Sciences Partners, Aperture Venture Partners, Lumira Capital, M.H. Carnegie & Co. and Arboretum Ventures.

Continue

Vascular Pharmaceuticals snares $9 mln

By Iris Dorbian — 11 months ago

Research Triangle Park, North Carolina-based Vascular Pharmaceuticals Inc, a diabetes-focused pharmaceutical company, has secured $9 million in Series A funding. The investors included Lumira Capital, Intersouth Partners and MPM Capital. In addition to the funding, Dr. Beni Rovinski, managing director of Lumira Capital, has been added to VPI’s board of directors.

Continue

DC Devices picks up $34 mln Series D

By Iris Dorbian — 2 years ago

DC Devices, a medical device firm focused on treating heart failure, has secured $34 million in Series D funding. Accelmed led the round with participation from investors that included Third Rock Ventures, General Catalyst Partners and Lumira Capital.

Continue

Cardiac Dimensions picks up $20 mln

By Iris Dorbian — 2 years ago

Cardiac Dimensions said Wednesday that it has raised $20 million in funding. M. H. Carnegie & Co. and Lumira Capital led the round. Cardiac Dimensions is a developer of minimally invasive treatments that address heart failure and related cardiovascular conditions.

Continue

BAROnova Closes Series C

By Angela Sormani — 3 years ago

trong>BAROnova has closed its Series C financing of $27.3 million, led by investments from Sante Ventures and Boston Scientific Corporation, an innovator of medical devices and technologies. Investors included Series B investors ONSET Ventures, Highland Capital Partners and Arboretum Ventures, along with new investor Lumira Capital. Financial terms were not disclosed.

Continue

Ontario Venture Capital Fund Commits $70 million to Three Funds

By Connie Loizos — 4 years ago

Ontario Venture Capital Fund (OVCF) has committed $70 million to three Ontario-focused VC funds: Lumira Capital II, Celtic House Venture Partners IV and Rho Canada Ventures II. PRESS RELEASE: Ontario Venture Capital Fund (OVCF) today announced it has recently made commitments totalling $70 million to three leading Ontario-focused venture capital funds: Lumira Capital II, Celtic House […]

Continue

U-Systems Closes on $6.5M

5 years ago

U-Systems, a developer of automated breast ultrasound technology, has closed on $6.5 million from investors including iD SoftCapital Group, Lumira Capital, PIIH, Radius Ventures, and Sycamore Ventures. The company will use the funds to complete a clinical study, and complete submissions for regulatory approval with the Food and Drug Administration. U-Systems is based in Sunnyvale, Calif.

Continue

Lumira Capital Raising New Fund

By PEHub Administrator — 7 years ago

Lumira Capital is planning to raise between $250 million and $300 million for its second fund, according to VentureWire. The Toronto-based VC firm was previously known as MDS Capital Corp., and focuses on the life sciences sector. www.lumiracapital.com

Continue